Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

Decera Clinical Education Oncology Podcast · Feb 26, 2021 · 26m

In this episode, Jorge Cortes, MD, and Eunice S. Wang, MD, discuss the clinical implications of 3 key studies in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) presented at the virtual ASH 2020 annual conference. Topics include:

The macrophage immune checkpoint inhibitor magrolimab in AML

The STAMP inhibitor asciminib in CML (the ASCEMBL trial)

Optimal dosing for the TKI ponatinib in CML

Presenters:

Jorge Cortes, MD

Director, Georgia Cancer Center

Eminent Scholar, Georgia Research Academy

Augusta, Georgia

Eunice S. Wang, MD

Professor, Oncology

Chief, Leukemia Service…